Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey

Vancelik, Serhat; Beyhun, Nazim E.; Acemoglu, Hamit; Calikoglu, Oksan
January 2007
BMC Public Health;2007, Vol. 7 Issue 1, p122
Academic Journal
Background: Commercial sources of information are known to have greater influence than scientific sources on general practitioners' (GPs) prescribing behavior in under developed and developing countries. The study aimed to determine the self-reported impact of pharmaceutical promotion on the decision-making process of prescription of GPs in Eastern Turkey. Methods: A cross-sectional, exploratory survey was performed among 152 GPs working in the primary health centers and hospitals in Erzurum province of Eastern Turkey in 2006. A self-administered structured questionnaire was used. The questionnaire included questions regarding sociodemographics, number of patients per day, time per patient, frequency of sales representative visits to GPs, participation of GPs in training courses on prescribing (in-service training, drug companies), factors affecting prescribing decision, reference sources concerning prescribing and self-reported and self-rated effect of the activities of sales representatives on GPs prescribing decisions. Results: Of 152 subjects, 53.3% were male and 65.8% were working at primary health care centers, respectively. Mean patient per day was 58.3 ± 28.8 patients per GP. For majority of the GPs (73.7%), the most frequent resource used in case of any problems in prescribing process was drug guides of pharmaceutical companies. According to self-report of the GPs, their prescribing decisions were affected by participation in any training activity of drug companies, frequent visits by sales representatives, high number of patient examinations per day and low year of practice (p < 0.05 for all). Conclusion: The results of this study suggest that for the majority of the GPs, primary reference sources concerning prescribing was commercial information provided by sales representatives of pharmaceutical companies, which were reported to be highly influential on their decision-making process of prescribing by GPs. Since this study was based on self-report, the influence reported by the GPs may have been underestimated.


Related Articles

  • GPs have 'unhealthy' relationship with reps.  // Pulse;6/2/2003, Vol. 63 Issue 22, p4 

    Reports on the criticism of journal 'BMJ' on the relationship between pharmaceutical industry and general practitioners on drug prescription consequences for patients in Great Britain.

  • Money-saving tips for dispensers. Phipps, Jeremy // GP: General Practitioner;2/13/2009, p53 

    The article offers practical tips for general practitioners (GPs) to cut cost on drug dispensing in England. One is to ensure that dispensers would not phone through orders. Another is to join a larger buying group for better discounts. GPs are also advised to monitor electricity, gas and other...

  • PCT curbs GPs' pharma links. Crump, Helen // Pulse;2/1/2007, Vol. 67 Issue 4, p12 

    The article reports on the urge of the Cambridgeshire Primary Care Trust for general practitioners (GPs) to limit their links with pharmaceutical companies in England. GP principals were required to get manager's consent before allowing sponsorship of meetings by drug companies. The new policy...

  • GPs reject drug waste criticism. Pedder, Cato // Pulse;5/24/2007, Vol. 67 Issue 20, p10 

    The article focuses on the rejection of general practitioners (GPs) concerning drug waste criticism in Great Britain. GPs responded angrily to the accusation due to their wasteful prescription, ramping up the pressure for switching to cheaper drugs. The National Health Service could save at...

  • Prescribing habits get greater scrutiny. Topham-Kindley, Liane // New Zealand Doctor;1/30/2008, p9 

    The article reports that prescribing habits of general practitioners (GPs) are under study in New Zealand. According to GPs, pharmacists are pressuring them to prescribe monthly, close control, rather than do stat dispensing which is every three months. The Pharmaceutical Agency (Pharmac) of New...

  • Scottish GPs defend use of non-generic drugs. Ward, Seamus // Public Finance;10/08/99, p8 

    Reports on the efforts of the Scottish general practitioners to defend use of non-generic drugs before Great Britain's Accounts Commission. Increased proportion of generic drugs from 1992 to 1999; Problems with the supply of generics.

  • Rural GP 'has nothing to hide.'. L. T. K. // New Zealand Doctor;12/13/2006, p3 

    The article reports on the historical arrangement between Central Otago, New Zealand general practitioner (GP) Verne Smith and his local pharmacist around close control prescribing. The physician prescribed monthly medication to ensure the viability of the sole Ranfurly pharmacy. According to...

  • US junior doctors found to be ignorant of drug companies' tactics. Spurgeon, David // BMJ: British Medical Journal (International Edition);5/1/2004, Vol. 328 Issue 7447, p1032 

    Reports that only a small proportion of medical residency programs in the United States teach doctors how to deal with pressures from the pharmaceutical industry. Success of the pharmaceutical industry in influencing doctors' prescribing decisions; Need for doctors to be aware of the conflicts...

  • PROMOTION OVERDOSE?  // Art of Healing;Dec2008-Feb2009, Vol. 4 Issue 25, p10 

    The article reports on a survey of general practitioners (GPs) conducted by CHOICE, Australia's Consumer Association, to find out how often GPs are being marketed too by pharmaceutical sales representatives, and how this might influence their decisions on what they prescribe. The survey shows...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics